Renal Cancer - Results from #4920

Incidence and histologic features of mixed renal tumors October 26, 2017

Clinical decision-making for immunotherapy in metastatic renal cell carcinoma October 26, 2017

Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma October 26, 2017

Updated recommendation on molecular-targeted therapy for metastatic renal cell cancer October 25, 2017

Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma October 25, 2017

Recent advances in localized RCC: A focus on VEGF and immuno-oncology therapies October 24, 2017

Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma October 24, 2017

Impact of marital status on renal cancer patient survival October 24, 2017

[Impressive extension into the right heart cavities and the inferior vena cava of renal carcinoma] October 23, 2017

The role of pazopanib on tumour angiogenesis and in the management of cancers: A review October 23, 2017

Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification October 23, 2017

[A Case Report of Splenic Metastasis of Renal Cell Carcinoma] October 21, 2017

Is Infection an Independent Risk Factor for Venous Thromboembolism? a Population-Based Case-Control Study October 21, 2017

Immunological effects of everolimus in patients with metastatic renal cell cancer October 20, 2017

Identification and validation of novel prognostic markers in Renal Cell Carcinoma October 20, 2017

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential October 20, 2017

Glutamine addiction in kidney cancer suppresses oxidative stress and can be exploited for real-time imaging October 19, 2017

Imaging and Screening of Kidney Cancer October 19, 2017

Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria October 19, 2017

Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases October 19, 2017

Page 247 of 459